Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes

Overview of attention for article published in Cardiovascular Diabetology, January 2021

Altmetric Badge

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 80 Mendeley

Summary Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Two years with GIOIA ‘Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes’: A prospective, multicentre, quasi‐experimental study on sodium‐glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors in diabetes clinical practice

Article in Diabetes Obesity and Metabolism (January 2024)

Sodium Glucose Transporter-2 Inhibitors (SGLT2Is)-TLRs Axis Modulates Diabetes

Article in Cell Biochemistry and Biophysics (September 2023)

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Therapy for the Primary and Secondary Prevention of Heart Failure in Patients With and Without Type 2 Diabetes Mellitus: A Systematic Review

Article in Cureus (April 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.